Enochian Biosciences Inc.

NASDAQ: ENOB · Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 9:58 PM

Enochian Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Cash & Equivalents
220.47K 1,874.5B 9.17M 20.66M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
19.85K 42,632.7B 68.64K 20.98K
Receivables
n/a n/a n/a 1.64K
Inventory
n/a n/a n/a n/a
Other Current Assets
1.78M 690.92B 393K n/a
Total Current Assets
2M 2,565.4B 9.57M 20.9M
Property-Plant & Equipment
1.75M 1,423B 1.74M 2.16M
Goodwill & Intangibles
159.36M 11,679.7B 73.26M 166.53M
Total Long-Term Assets
161.13M 55,735.4B 75.07M 168.71M
Total Assets
163.13M 58,300.8B 84.63M 189.61M
Account Payables
9.45M 5,296.8B 1.4M 320.56K
Deferred Revenue
n/a n/a n/a 1.18M
Short-Term Debt
2.94M 4,818.4B 1.45M 292.41K
Other Current Liabilities
17.92M 907.91B 3.6M 1.27M
Total Current Liabilities
30.31M 11,023.1B 6.45M 1.89M
Long-Term Debt
842.39K 775.59B 5.56M 7.02M
Other Long-Term Liabilities
n/a n/a n/a 6.04M
Total Long-Term Liabilities
842.39K 775.59B 5.56M 13.06M
Total Liabilities
31.15M 11,798.7B 12.01M 14.94M
Total Debt
3.79M 5,594B 7.02M 7.31M
Common Stock
15.5K 6.37B 5.3K 5.22K
Retained Earnings
-324.68M -244,029.3B -204.35M -90.91M
Comprehensive Income
-170.85K -29.88B -30.44K -10.83K
Shareholders Equity
131.98M 46,502.1B 72.62M 174.66M
Total Investments
n/a n/a n/a n/a